Undifferentiated sarcoma of the maxillary sinus: Report of a rare case in an adult

被引：5

作者：

Hosokawa, Seiji ^{[1
]}

Takebayashi, Satoru ^{[1
]}

Mineta, Hiroyuki ^{[1
]}

Suzuki, Kazuya ^{[2
]}

Baba, Satoshi ^{[3
]}

机构：

[1] Hamamatsu Univ Sch Med, Dept Otolaryngol, Shizuoka 4313192, Japan

[2] Hamamatsu Univ Sch Med, Dept Surg 1, Hamamatsu, Shizuoka 4313192, Japan

[3] Hamamatsu Univ Sch Med, Div Pathol, Hamamatsu, Shizuoka 4313192, Japan

来源：

AURIS NASUS LARYNX | 2009年 / 36卷 / 01期

关键词：

Undifferentiated sarcoma; Maxillary sinus; Combination chemotherapy; SOFT-TISSUE SARCOMA; INTERGROUP RHABDOMYOSARCOMA;

D O I：

10.1016/j.anl.2008.05.001

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

A 51-year-old man complained of left facial swelling and recurrent nasal bleeding. A giant solid tumor in the left maxillary sinus was detected on head CT and MRI, and this tumor was destroying the maxilla and extending into the orbit, pterygoid muscle and posterior paranasal sinuses. The resected specimen consisted of spindle cells containing necrotic material. Histological examination revealed immature tumor cells, and immunohistological study of the tumor showed staining was only positive for vimentin. We accordingly diagnosed undifferentiated sarcoma in the maxillary sinus. Combination chemotherapy with vincristine, doxorubicin, cyclophosphamide/ifosfamide with mesna and etoposide was administered; however, the tumor was unresponsive and the patient died after around 3 months. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

引用

页码：92 / 95

页数：4

共 11 条

[1] Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide [J].

Arndt, CAS ;

Nascimento, AG ;

Schroeder, G ;

Schomberg, PJ ;

Neglia, JP ;

Sencer, SF ;

Silberman, TL ;

Moertel, CL ;

Tillisch, JK ;

Miser, JS .

EUROPEAN JOURNAL OF CANCER, 1998, 34 (08) :1224-1229

[2] RHABDOMYOSARCOMA OF THE PARAPHARYNGEAL SPACE IN AN ADULT PATIENT - AN IMMUNOHISTOCHEMICAL STUDY [J].

BERGAMINI, JA ;

NADIMI, H ;

KUO, PC .

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1989, 47 (04) :414-417

[3] High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma [J].

Boulad, F ;

Kernan, NA ;

LaQuaglia, MP ;

Heller, G ;

Lindsley, KL ;

Rosenfield, NS ;

Abramson, SJ ;

Gerald, WL ;

Small, TN ;

Gillio, AP ;

Gulati, SC ;

O'Reilly, RJ ;

Ghavimi, F .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (05) :1697-1706

[4] RHABDOMYOSARCOMA OF THE ORAL SOFT-TISSUES [J].

BRAS, J ;

BATSAKIS, JG ;

LUNA, MA .

ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTOLOGY, 1987, 64 (05) :585-596

[5]

COINDRE JM, 1986, CANCER-AM CANCER SOC, V58, P306, DOI 10.1002/1097-0142(19860715)58:2<306::AID-CNCR2820580216>3.0.CO

[6]

2-7

[7] THE THIRD INTERGROUP RHABDOMYOSARCOMA STUDY [J].

CRIST, W ;

GEHAN, EA ;

RAGAB, AH ;

DICKMAN, PS ;

DONALDSON, SS ;

FRYER, C ;

HAMMOND, D ;

HAYS, DM ;

HERRMANN, J ;

HEYN, R ;

JONES, PM ;

LAWRENCE, W ;

NEWTON, W ;

ORTEGA, J ;

RANEY, RB ;

RUYMANN, FB ;

TEFFT, M ;

WEBBER, B ;

WIENER, E ;

WHARAM, M ;

VIETTI, TJ ;

MAURER, HM .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) :610-630

[8]

KANAMARU R, 1991, JPN J CLIN ONCOL, V21, P227

[9]

MAUER HM, 1997, CANCER, V40, P2015

[10]

WHARAM MD, 1984, CANCER-AM CANCER SOC, V53, P1016, DOI 10.1002/1097-0142(19840215)53:4<1016::AID-CNCR2820530432>3.0.CO

← 1 2 →